External validation of an artificial intelligence tool for fracture detection in children with osteogenesis imperfecta: a multireader study - Scorecard - MDSpire
Advertisement
External validation of an artificial intelligence tool for fracture detection in children with osteogenesis imperfecta: a multireader study
Clinical Scorecard: Validation of an AI-Based Tool for Detecting Fractures in Pediatric Patients with Osteogenesis Imperfecta: A Multireader Analysis
At a Glance
Category
Detail
Condition
Osteogenesis imperfecta (OI), a genetic skeletal fragility disorder with increased fracture risk
Key Mechanisms
Skeletal fragility leading to multiple fractures, with bone abnormalities complicating fracture detection
Target Population
Children under 18 years with genetically confirmed osteogenesis imperfecta
Care Setting
Pediatric radiology departments in tertiary care hospitals
Key Highlights
OI causes frequent fractures in children, often difficult to detect due to bone remodeling and healing changes.
AI tools for fracture detection have shown improved diagnostic performance but lack validation in pediatric rare diseases like OI.
This study evaluated a commercial AI fracture detection tool's performance in pediatric OI patients without prior specific training on this population.
Guideline-Based Recommendations
Diagnosis
Use consensus expert radiologist opinion as ground truth for fracture identification in OI patients.
Label fractures as acute or healing based on radiographic features such as callus or periosteal reaction.
Consider AI assistance as an adjunct to radiologist interpretation to potentially improve fracture detection.
Management
Integrate AI tools cautiously in clinical practice for pediatric OI fracture detection, acknowledging current lack of specific training on this population.
Maintain expert radiologist oversight when interpreting AI outputs, especially in rare disease contexts.
Monitoring & Follow-up
Conduct multireader studies with washout periods to assess AI impact on diagnostic accuracy.
Monitor AI performance continuously to identify potential biases or limitations in pediatric rare disease fracture detection.
Risks
Potential for missed fractures due to bone remodeling and atypical appearances in OI.
Risk of AI misclassification or reduced sensitivity in populations not included in training datasets.
Possibility of patient discrimination or bias if AI tools are implemented without validation in rare disease groups.
by Cato Pauling, Harsimran Laidlow-Singh, Emily Evans, David Garbera, Rosalind Williamson, Ranil Fernando, Kate Thomas, Helena Martin, Owen J. Arthurs, Susan C. Shelmerdine
Colorectal cancer (CRC) impacts about 1 in 13,000 pregnancies in the United States. This article follows the case of a 36-year-old woman diagnosed with CRC while pregnant and highlights considerations around CRC diagnosis and cancer treatment during pregnancy.